Implementation of a Pharmacist-Based, Post-Chemotherapy Follow-up Clinic

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to determine the impact of pharmacists on reducing chemotherapy-related side effects by providing education before and after patients receive intravenous chemotherapy at one of Cedars-Sinai outpatient infusion centers. Participants will be interviewed via telephone within 7 business days after receiving intravenous chemotherapy from the outpatient cancer center infusion clinic.

Detailed Description
-----------------
The study involves participation at a single timepoint only. Participants who consented to participate and are considered eligible will be interviewed by a pharmacist via phone at approximately 7 business days after receiving intravenous chemotherapy infusion. Phone call will be made between the hours of 9am - 6pm on Monday - Saturday. Calls are anticipated to last between 15 to 20 minutes. Participants will be asked if they have experienced any adverse events since the infusion, whether or not they have had any barriers taking supportive care medications, and if the patient understands how to manage potential adverse events. If applicable, participants will be provided further education on optimizing adverse events, guided on proper medication administration times, and will be provided with non-pharmacological clinical pearls to minimize chemotherapy-related side effects and optimize supportive care management. If unable to reach the participant or caregiver after three attempts, the participant will be considered ineligible. Participants can decline participation at any time during the phone call.

Official Title
-----------------
Implementation of a Pharmacist-Based, Post-Chemotherapy Follow-up Clinic

Conditions
-----------------
Cancer

Intervention / Treatment
-----------------
* Behavioral: Follow-up phone interview


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: At least 18 years old Diagnosed with cancer and is receiving treatment with intravenous chemotherapy Treatment initiated at Cedars-Sinai Cancer Samuel Oschin Cancer Center (SOCC) or Cedars-Sinai Cancer Beverly Hills (CSCBH) English-speaking or lives with English-speaking person Access to a working phone Exclusion Criteria: Received follow-up calls through other specialty pharmacy program History of infusion related reactions Declined participation on follow-up interview Age less than 18 years old Non-English speaking Electronic health record flagged for research opt out

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Intervention group<br>Participants receive a follow-up phone call from a pharmacist approximately 7 business days after receiving intravenous chemotherapy infusion | Behavioral: Follow-up phone interview<br>* Follow-up phone interview within 7 business days after receiving intravenous chemotherapy<br>* Other names: Follow-up call;|
| Control group<br>Participants do not receive a follow-up phone call from a pharmacist after receiving intravenous chemotherapy infusion | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Hospital admission related to chemotherapy within 30-day post treatment | Number of hospital admission related to chemotherapy | 30 days after receiving the first intravenous chemotherapy | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Pharmacist, Follow up clinic